Amyloid PET and changes in clinical management among ethnoracially diverse and clinically atypical individuals: Findings from New IDEAS
New IDEAS demonstrated that amyloid PET use among ethnoracially diverse Medicare beneficiaries and those with atypical and typical clinical presentations of AD leads to changes in clinical management, highlighting the value of this biomarker in a real-world clinical care setting.
Authors
- Justin Romanoff (ORCID: https://orcid.org/0000-0001-7058-9621)
- Robert A. Rissman (ORCID: https://orcid.org/0000-0001-9245-8278)
- Christopher J. Weber
- Maria Carrillo
- Barry A. Siegel (ORCID: https://orcid.org/0000-0001-6246-5792)
- Karen Smith
- Andrew March
- Consuelo H. Wilkins (ORCID: https://orcid.org/0000-0002-8043-513X)
- Emily E. Glavin (ORCID: https://orcid.org/0000-0003-0751-770X)
- Charles Windon (ORCID: https://orcid.org/0000-0001-8719-1206)
- Bruce E. Hillner
- Ilana F. Gareen (ORCID: https://orcid.org/0000-0002-0457-5595)
- Lucy Hanna (ORCID: https://orcid.org/0000-0003-3298-0771)
- Constantine Gatsonis
- Peggye Dilworth‐Anderson
- Rachel A. Whitmer
- Gil D. Rabinovici
Institutions
- American College of Radiology (US)
- University of North Carolina at Chapel Hill (US)
- University of Southern California (US)
- Alzheimer's Association (US)
- University of California, San Francisco (US)
- Virginia Commonwealth University (US)
- Brown University (US)
- Mallinckrodt (United States) (US)
- University Memory and Aging Center (US)
- University of California, Davis (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70862_110827
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00